155 related articles for article (PubMed ID: 29187485)
1. Primary Urinary Tract Lymphoma: Rare but Aggressive.
Lontos K; Tsagianni A; Msaouel P; Appleman LJ; Nasioudis D
Anticancer Res; 2017 Dec; 37(12):6989-6995. PubMed ID: 29187485
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
[TBL] [Abstract][Full Text] [Related]
3. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
4. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
5. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis.
He LF; Zhang JD; Chen XX; Wei RL
BMC Ophthalmol; 2022 Dec; 22(1):486. PubMed ID: 36514001
[TBL] [Abstract][Full Text] [Related]
7. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
8. Primary renal lymphoma: a population-based study in the United States, 1980-2013.
Chen J; Peng J; Zheng Y; Li S; Yang P; Wu X; Tian H; Liu H; Yang S; Wang W; Wu B
Sci Rep; 2019 Oct; 9(1):15125. PubMed ID: 31641184
[TBL] [Abstract][Full Text] [Related]
9. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
[TBL] [Abstract][Full Text] [Related]
10. Unstaged Diffuse Large B-Cell Lymphoma in the United States: Predictors and Patient Outcomes.
Bista A; Sharma S; Rijwani T; Shah BK
Anticancer Res; 2017 Apr; 37(4):1935-1939. PubMed ID: 28373463
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
13. Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis.
Jia J; Chen W
Radiat Oncol; 2021 Oct; 16(1):193. PubMed ID: 34600539
[TBL] [Abstract][Full Text] [Related]
14. Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).
Taneja A; Kumar V; Chandra AB
Eur J Haematol; 2020 May; 104(5):390-399. PubMed ID: 31769538
[TBL] [Abstract][Full Text] [Related]
15. Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis.
Liu ZH; Yang LC; Song P; Fang K; Zhou J; Peng ZF; Dong Q
Front Oncol; 2021; 11():609882. PubMed ID: 34336635
[TBL] [Abstract][Full Text] [Related]
16. Features and outcomes of diffuse large B-cell lymphoma of the thyroid in a large contemporary cohort.
Costa LJ; Xavier AC
Leuk Lymphoma; 2014 Feb; 55(2):283-7. PubMed ID: 23647064
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.
Koff JL; Rai A; Flowers CR
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e115-e121. PubMed ID: 29273217
[TBL] [Abstract][Full Text] [Related]
20. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]